EP3099306
Steraefnasamband til að nota við að meðhöndla lifrarheilakvilla
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.1.2015EP published:
12.12.2018EP application number:
15705691.2
EP translation filed:
6.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
13.1.2035Expiry date:
13.1.2027Next due date:
31.1.2027
Title:
STEROID COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY
Timeline
Today
14.1.2015EP application
12.12.2018EP Publication
6.2.2019Translation submitted
15.3.2019Registration published
13.1.2027Expires
Owner
Name:
Umecrine Cognition ABAddress:
Karolinska Institutet Science Park Fogdevreten 2, 171 65 Solna, SE
Inventor
Name:
DOVERSKOG, MagnusAddress:
SE 114 20 Stockholm, SE
Name:
MÖHLER, HannsAddress:
Maennedorf, CH
Name:
FELIPO, VicenteAddress:
Naquera, ES
Name:
BÄCKSTRÖM, TorbjörnAddress:
SE 907 38 Umeå, SE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
1450089Date:
29.1.2014Country:
SE
Classification
Categories:
A61K 31/568, A61K 31/198, A61K 31/216, A61K 31/437, A61K 31/7016, A61P 25/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 4.4.2019
Expires: 13.1.2020
Payer: Árnason Faktor
Number: 6
Paid: 21.1.2020
Expires: 13.1.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 18.1.2021
Expires: 13.1.2022
Payer: CPA Global (Patrafee) AB
Number: 8
Paid: 19.1.2022
Expires: 13.1.2023
Payer: CPA Global (Patrafee) AB
Number: 9
Paid: 18.1.2023
Expires: 13.1.2024
Payer: CPA Global (Patrafee) AB
Number: 10
Paid: 22.1.2024
Expires: 13.1.2025
Payer: CPA Global (Patrafee) AB
Number: 11
Paid: 23.1.2025
Expires: 13.1.2026
Payer: CPA Global (Patrafee) AB
Number: 12
Paid: 22.1.2026
Expires: 13.1.2027
Payer: CPA Global (Patrafee) AB